+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Injury Treatment Market - Global Forecast 2026-2032- Product Image
Vascular Injury Treatment Market - Global Forecast 2026-2032- Product Image
New

Vascular Injury Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986092
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vascular injury treatment market is shaped by continuous clinical innovation and evolving medical technology. Senior decision-makers must navigate changing regulatory expectations and competitive pressures, aligning strategies to achieve both superior patient care and organizational performance.

Market Snapshot: Vascular Injury Treatment Market Size and Outlook

The vascular injury treatment market grew from USD 3.41 billion in 2025 to USD 3.61 billion in 2026 and is projected to reach USD 5.18 billion by 2032, advancing at a CAGR of 6.15%. This expansion reflects a dynamic environment influenced by clinical progress, emerging technology, and increasingly complex regulatory and reimbursement frameworks. Sustained growth in this market depends on a nuanced understanding of procedural standards, investment priorities, and adaptive operational models in line with shifting care protocols.

Scope & Segmentation

  • Product Types: Catheters—including aspiration, balloon, and delivery models—are critical tools, complemented by embolic protection devices such as distal filters and proximal occlusion technologies. Stent solutions encompass bare metal, covered, and drug-eluting products, while pharmacologic treatments include thrombolytics, anticoagulants, and antiplatelets. Vascular grafts are available in both biological and synthetic formats.
  • Treatment Modalities: Endovascular repair covers interventions like aortic, carotid, and peripheral stenting, and is supported by open surgical procedures and pharmacotherapy for targeted treatment.
  • Care Settings: The primary delivery environments are hospitals, ambulatory surgical centers, and specialty clinics. Each segment demands tailored procedural approaches, supply chain organization, and logistical support to optimize outcomes.
  • Injury Classifications: Management extends across arterial, venous, microvascular, and capillary injuries, with therapy and device requirements varying based on clinical complexity and site-specific factors.
  • Technological Advances: The market benefits from advanced imaging modalities, device miniaturization, innovative materials, digital planning platforms, and data-driven evidence systems, each supporting more precise and efficient interventions.
  • Regions: Strategic considerations differ across the Americas, Europe, the Middle East & Africa, and Asia-Pacific. Each region introduces unique regulatory, reimbursement, and distribution variables that shape procurement and adoption strategies.

Key Takeaways for Senior Decision-Makers

  • Integrated endovascular and pharmacologic approaches now inform care protocols, supporting improved hemostasis and tissue preservation while enhancing workflow and patient throughput.
  • Advancements like device miniaturization and modular systems increase minimally invasive procedures and inform procurement strategies for varied clinical demands.
  • Provider networks refine device portfolios for processes and supply compatibility, prioritizing flexible products that facilitate integrated delivery pathways.
  • Technology adoption is now driven by real-world evidence with outcomes-based frameworks directing both reimbursement and procurement to demonstrate value to payers.
  • Strategic partnerships and platform solutions are essential for market entrants, providing new avenues to address regulatory requirements and accelerate commercialization efforts.
  • Adapting market entry tactics by accounting for regional practices and reimbursement diversity supports scalable growth and successful product adoption.

Tariff Impact on US Supply Chains and Procurement

Recent US trade tariffs have led device manufacturers to diversify sourcing and expand regional production. Hospitals and ambulatory centers adapt procurement prioritizing local continuity and cost control, emphasizing vendor relationships. Smaller device firms foster collaborative partnerships to counter tighter margins. These shifts increase the need for adaptable, resilient supply chains and informed vendor management, while maintaining steady clinical outcomes.

Methodology & Data Sources

This report relies on qualitative interviews with clinicians and procurement leads, integrating systematic literature review with peer-reviewed articles, regulatory documents, and registry information. Analytical processes combined thematic coding and comparative evaluation to ensure credible, actionable market insights.

Why This Report Matters: Strategic Value for Stakeholders

  • Equips stakeholders with evidence-based procurement and product development guidance by aligning regulatory and commercial trends with clinical best practices in the vascular injury treatment market.
  • Provides actionable competitive intelligence on supply chain resilience, device advances, and evolving reimbursement policies, supporting informed technology adoption and portfolio development.
  • Enables manufacturers, hospital networks, and payers to synchronize investment and technology integration as care models and payment structures advance.

Vascular Injury Treatment Market: Competitive and Operational Insights

This report offers in-depth competitive and operational analysis, highlighting segmentation, driver evaluation, and practical guidance for market positioning. Specialized coverage of supply chain resilience, platform technology integration, and regulatory strategy supports identification of emerging risks and opportunities relevant to strategic planning.

Conclusion

The vascular injury treatment market is advancing toward integrated, outcome-driven care models. Leaders who adapt to technology trends, policy changes, and regional demands are best positioned for sustained success and improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vascular Injury Treatment Market, by Product
8.1. Catheters
8.1.1. Aspiration Catheters
8.1.2. Balloon Catheters
8.1.3. Delivery Catheters
8.2. Embolic Protection Devices
8.2.1. Distal Filters
8.2.2. Proximal Occlusion Devices
8.3. Stents
8.3.1. Bare Metal Stents
8.3.2. Covered Stents
8.3.3. Drug Eluting Stents
8.4. Thrombolytic Drugs
8.4.1. Streptokinase
8.4.2. Tissue Plasminogen Activator
8.4.3. Urokinase
8.5. Vascular Grafts
8.5.1. Biological Grafts
8.5.2. Synthetic Grafts
9. Vascular Injury Treatment Market, by Treatment Modalities
9.1. Endovascular Repair
9.1.1. Aortic Stenting
9.1.2. Carotid Stenting
9.1.3. Peripheral Stenting
9.2. Open Surgery
9.3. Pharmacotherapy
9.3.1. Anticoagulants
9.3.2. Antiplatelet Drugs
9.3.3. Thrombolytics
10. Vascular Injury Treatment Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Specialty Clinics
11. Vascular Injury Treatment Market, by Injury Type
11.1. Arterial Injury
11.2. Capillary Injury
11.3. Microvascular Injury
11.4. Venous Injury
12. Vascular Injury Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Vascular Injury Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Vascular Injury Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Vascular Injury Treatment Market
16. China Vascular Injury Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. B. Braun Melsungen AG
17.7. Becton, Dickinson and Company
17.8. Boston Scientific Corporation
17.9. Cardinal Health Inc.
17.10. Edwards Lifesciences Corporation
17.11. Johnson & Johnson
17.12. Medtronic plc
17.13. Penumbra, Inc.
17.14. Teleflex Incorporated
17.15. Terumo Corporation
17.16. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 166. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 168. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 173. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 188. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 190. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 191. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 193. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 194. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 195. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 196. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 197. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 215. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 216. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 217. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 218. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 220. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 221. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 222. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 225. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 227. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 228. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 229. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 230. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 231. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 232. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 233. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 234. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 235. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 249. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 251. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 252. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 253. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 254. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 255. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 256. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 257. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 258. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 259. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 261. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 263. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 264. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 265. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 266. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 267. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 268. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 269. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 270. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 271. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 273. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 275. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 276. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 277. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 278. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 279. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 280. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 281. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 282. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 283. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 284. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)
TABLE 298. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 300. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
TABLE 301. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 302. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
TABLE 303. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2032 (USD MILLION)
TABLE 304. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 305. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2032 (USD MILLION)
TABLE 306. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2032 (USD MILLION)
TABLE 307. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 308. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Vascular Injury Treatment market report include:
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Penumbra, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.18 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 249 Pages
  • Global
From
Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Aortic & Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032 - Product Image

Aortic & Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032 - Product Image

Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From

About the Vascular Injury Treatment Market

The Vascular Injury Treatment market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. It includes a variety of products and services designed to treat vascular injuries, such as endovascular stents, embolic protection devices, and vascular closure devices. These products are used to treat a variety of conditions, including peripheral artery disease, stroke, and aneurysms. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. Additionally, the rising geriatric population and the increasing awareness of vascular injury treatments are expected to drive the market growth. Some of the major companies in the Vascular Injury Treatment market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Johnson & Johnson, and Terumo Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.